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Opportunistic  fungal  pathogens  cause  severe, 
often fatal, disease in immunosuppressed individ-
uals, who have impaired adaptive immune re-
sponses to eradicate these infections (Corti et al., 
2009). The number of individuals susceptible 
to opportunistic fungal infections is increasing 
globally, although currently there are no vac-
cines against any fungal pathogen in clinical use. 
Pneumocystis jirovecii, the fungal organism that 
causes Pneumocystis pneumonia in humans, is 
a common cause of morbidity and mortality in 
individuals with HIV-AIDS or other immuno-
suppressive states such as chronic treatment with 
bone marrow–suppressive chemotherapeutics or 
high-dose corticosteroids (Morris et al., 2004; 
Thomas and Limper, 2004). The mainstay of 
prevention and treatment of Pneumocystis pneu-
monia involves the use of antimicrobials such as 
trimethoprim-sulfamethoxazole, of which there 
is concern for evolving microbial resistance 
(Nahimana et al., 2003; Huang et al., 2004a; 
Crothers et al., 2005).
Although CD4+ T cells and adaptive immune 
responses are required for host defense against 
Pneumocystis,  little  is  understood  regarding  the 
evolution of protective cellular and humoral re-
sponses after exposure to fungi. Antibodies are 
not an absolute requirement for host resistance 
against  Pneumocystis,  although  antibodies  pro-
duced in mouse hosts vaccinated with Pneumo-
cystis  can  prevent  and  clear  existing  infections 
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Host defense against opportunistic fungi requires coordination between innate and adap-
tive immunity for resolution of infection. Antibodies generated in mice vaccinated with the 
fungus Pneumocystis prevent growth of Pneumocystis organisms within the lungs, but the 
mechanisms whereby antibodies enhance antifungal host defense are poorly defined. Nearly 
all species of fungi contain the conserved carbohydrates -glucan and chitin within their 
cell walls, which may be targets of innate and adaptive immunity. In this study, we show 
that natural IgM antibodies targeting these fungal cell wall carbohydrates are conserved 
across many species, including fish and mammals. Natural antibodies bind fungal organisms 
and enhance host defense against Pneumocystis in early stages of infection. IgM antibodies 
influence recognition of fungal antigen by dendritic cells, increasing their migration to 
draining pulmonary lymph nodes. IgM antibodies are required for adaptive T helper type 2 
(Th2) and Th17 cell differentiation and guide B cell isotype class-switch recombination 
during host defense against Pneumocystis. These experiments suggest a novel role for the 
IgM isotype in shaping the earliest steps in recognition and clearance of this fungus.  
We outline a mechanism whereby serum IgM, containing ancient specificities against 
conserved fungal antigens, bridges innate and adaptive immunity against fungal organisms.
© 2010 Rapaka et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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of antibodies targeting conserved fungal cell wall carbohydrates 
-glucan, chitin, and mannan. BALB/c mice were challenged 
with Pneumocystis murina intratracheally, and Ig responses were 
monitored. Unexpectedly, we observed significant quantities 
of IgM reactive with both laminarin, a primarily -1,3 linked 
glucan (the predominant -glucan linkage found in fungal 
cell walls), and chitosan/chitin, a polymer of 75–85% deacety-
lated chitin, before Pneumocystis challenge. These IgM levels 
rapidly increased in serum through 2 d after challenge and 
subsided to approach baseline levels by 7 d (Fig. 1 A). Of note, 
IgM in the serum was not reactive with -1,6 linked mannan, 
underscoring the intrinsic specificity of the nAb repertoire 
(Mouthon et al., 1995; Yang et al., 1998). Quantities of IgG 
targeting -glucan and chitin at baseline were at the lower 
limit of detection compared with quantities of IgM against 
these antigens. Using mouse reference serum, we found that 
the mean concentration of antichitin IgM in BALB/c mice 
was 451 ± 36 ng/ml, and anti–-1,3 glucan IgM was 386 ± 
18 ng/ml. Levels in C57BL/6 mice were similar with a mean 
antichitin IgM level of 228 ng/ml and anti–-1,3 glucan IgM 
of 640 ng/ml. This ELISA reactivity is caused by the variable 
region, as irrelevant mouse IgMs such as DX-5 (which recog-
nizes CD49b) or 11E10 (which recognizes lipopolysaccharide) 
had no reactivity in these assays (unpublished data). Addition-
ally, serum from secreted IgM (sIgM/) mice also lacked re-
activity in these assays.
Anti–-glucan and antichitin antibodies are present  
in germ-free mice and are evolutionarily conserved
As IgM specificities targeting -glucan and chitosan/chitin 
are present in serum of mice reared in specific pathogen-free 
(SPF) conditions, we questioned whether adventitious expo-
sure to environmental pathogens or colonization of the gut 
by bacterial or fungal organisms might induce differentiation 
of B cells producing these antibody specificities. Analysis of 
serum from C57BL/6 mice reared in germ-free conditions 
demonstrated similar quantities of IgM targeting -glucan 
and chitosan/chitin compared with mice reared in SPF con-
ditions (Fig. 1 B), suggesting that these IgMs are nAbs, pro-
duced in the absence of exogenous microbial stimulation. 
Because high quantities of IgMs targeting -glucan and chi-
tin were present in SPF mice, we assessed the localization of 
B cells spontaneously producing -glucan–specific IgM. B-1 
B cells are considered the predominant B cell subset involved 
in the production of natural IgM antibodies and are present in 
pleural and peritoneal spaces in mice (Boes, 2000). Compar-
ing cells derived from peritoneal lavage, spleen, bone marrow, 
and lung for the ability to produce IgM reactive with -glucan 
by ELISPOT, we found that the primary site of cells produc-
ing IgM reactive with -glucan was the spleen (Fig. 1 C). It 
was previously identified that peritoneal B-1 cells migrate 
into the spleen and other secondary lymphoid organs upon 
stimulation  by  toll-like  receptor  ligands  (Kawahara  et  al., 
2003; Ha et al., 2006; Yang et al., 2007), where they differentiate 
into antibody-secreting cells. Upon purification of CD5+IgM+ 
B cells and CD5 cells from the spleen, the majority of the 
(Roths and Sidman, 1993; Zheng et al., 2001). The specificities 
of protective antibodies, the relevance of particular isotypes, and 
the contributions of antibodies to an evolving host immune re-
sponse against Pneumocystis are poorly characterized. Contribu-
tions of antibody isotype as a correlate of effector function have 
been explored in greater detail against other fungal pathogens. 
In Cryptococcus neoformans infection, for example, mAb IgG sub-
type plays a critical role in determining whether antibodies 
targeting the cell capsular antigen glucuronoxylomannan are 
protective or detrimental to host defense (Nussbaum et al., 
1996). IgM antibodies against fungi can increase complement 
deposition and complement-dependent and -independent 
phagocytosis by APCs (Zhang et al., 1998; Han et al., 2001; 
Taborda  and  Casadevall,  2002),  and  some  IgM  specificities 
against fungi demonstrate direct antimicrobial effects (Xander 
et al., 2007). However, there has been little evaluation of the role 
of native IgM antibodies in the evolution of host responses to 
fungal infection. Humans with mutations in CD40L resulting in 
the X-linked hyper-IgM syndrome are susceptible to Pneumo-
cystis pneumonia, suggesting that IgM in and of itself is not suf-
ficient to provide host resistance against this infection.
Fungal organisms, of which there are an estimated 1.5 
million different species, contain cell walls that are remark-
ably similar. It is estimated that 90% of the fungal cell wall 
consists of polysaccharides, and at the core of this cell wall 
exist two carbohydrates, -glucan and chitin. Nearly all spe-
cies of pathogenic fungi, including Pneumocystis sp., contain the 
conserved cell wall carbohydrates -glucan, chitin, and man-
nan, which are emerging as targets of multiple host defense 
pathways (Ezekowitz et al., 1991; Roth et al., 1997; Steele   
et al., 2003; Latgé, 2007). The abundance of these antigens in 
fungi is underscored by evidence demonstrating that quanti-
ties of -glucan in the serum are significantly elevated in pa-
tients infected with P. jirovecii and other opportunistic fungal 
pathogens (Marty et al., 2007; Persat et al., 2008).
Natural antibodies (nAbs) are predominantly of the IgM 
isotype, generated without the requirement for exogenous 
antigenic stimulation, and are primarily produced by the B-1 
subset of B cells. In this study, we present evidence for the exis-
tence of natural IgM antibodies targeting the fungal cell wall 
carbohydrates -glucan and chitin, which are specificities con-
served over evolution. We show that nAbs are protective in the 
early stages of host defense against pulmonary mucosal infec-
tion with Pneumocystis and further demonstrate that IgM anti-
bodies  mediate  processes  of  pulmonary  DC  migration  and 
shape the generation of adaptive Th and induced antibody re-
sponses in response to pulmonary fungal infection. Collectively, 
these data indicate a novel role for IgM in host defense against 
fungi and suggest that selective pressure may exist on the host 
to encode native IgMs with specificity for fungal antigens.
RESULTS
Anticarbohydrate antibody responses during  
Pneumocystis infection
We first assessed the hypothesis that exposure to the opportu-
nistic fungal pathogen Pneumocystis might lead to the generation JEM VOL. 207, December 20, 2010 
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are present in the preimmune repertoire by assessing human 
and nonhuman primate umbilical cord blood for IgM reac-
tivity against -glucan and chitosan/chitin. As IgM does not 
cross the placenta (Mostov, 1994; Ben-Hur et al., 2005), IgM 
present in umbilical cord blood represents specificities gener-
ated in the preimmune repertoire by the fetus. We observed 
the presence of anti–-glucan and antichitosan/chitin IgM 
antibodies in both human cord blood (Fig. 1 F) as well as cord 
blood from rhesus macaque (Fig. 1 G). Similar to mouse 
serum, the reactivity of human serum depends on the variable 
region, as purified human IgM Fc fragments or myeloma   
IgM  lacking  carbohydrate  specificity  had  no  reactivity  in 
these assays (Fig. S1). As further evidence that these IgMs exist 
within the nAb repertoire, chitin-binding IgM+ B cells were 
sorted by FACS, and single-cell PCR was performed to   
determine the sequences across the  VH chain. Genetic analysis 
revealed that several of the high chitin-binding clones cluster 
with E06, a canonical nAb recognizing oxidized antiphos-
phatidylcholines and capsular polysaccharide (Fig. S2; Chou 
et al., 2009). Thus, IgM specificities exist that target impor-
tant structural carbohydrates present in most fungal cell walls. 
These IgM specificities are conserved across multiple species 
and do not require exogenous microbial stimulation for   
their  production. Additionally,  the  genetic  rearrangements 
encoding these IgMs in mice appear similar to those seen for 
other nAbs.
spontaneous anti–-glucan IgM production was confined to 
the CD5+ population (Fig. 1 D), suggesting that the cells gen-
erating anti–-glucan IgM are within the B-1a subset, which 
are known for their spontaneous production of nAbs reactive 
with self and microbial antigens. Our data support experi-
ments suggesting that the spleen is a common site for nAb-
secreting cells such as those secreting IgM reactive with fungal 
cell wall carbohydrates (Yang et al., 2007).
As nAbs have been demonstrated to play a critical role in 
host defense against bacterial and viral infections (Boes et al., 
1998b; Ochsenbein et al., 1999), likely acting at the earliest 
moments upon pathogen exposure much like membrane-
bound pattern recognition receptors (PRRs), it was hypothe-
sized that nAb specificities have been selected over evolution 
partly as a function of their ability to defend against infection 
(Ochsenbein and Zinkernagel, 2000). We questioned whether 
antibodies targeting fungal cell wall carbohydrates are present 
among the earliest evolved animals with adaptive, combinato-
rial immune systems. The serum of the channel catfish, Ictal-
urus  punctatus,  which  contains  a  tetrameric  homologue  of 
IgM, was assessed for IgM reactivity against -glucan and chi-
tosan/chitin. Antibodies with these reactivities were present 
in catfish serum, with quantities of -glucan–specific IgM 
higher than chitosan/chitin-specific IgM (Fig. 1 E). As mice 
raised in germ-free conditions may still be exposed to fungal 
carbohydrates, we determined whether these IgM specificities 
Figure 1.  nAbs against conserved fungal 
cell wall carbohydrates are produced in 
diverse species, without requirement for 
exogenous antigenic stimulation. (A) Char-
acterization of serum IgM antibodies in BALB/c 
mice before and after intratracheal chal-
lenge with Pneumocystis (PC) against fungal 
cell wall carbohydrates laminarin (primarily 
-1,3 linked glucan), chitosan/chitin, and 
mannan by ELISA (n = 5–6 mice per time 
point from two independent experiments).  
(B) Relative quantity of IgM specific for  
-glucan and chitosan/chitin in C57BL/6 mice 
reared under conventional SPF or germ-free 
(GF) conditions was measured by ELISA (n = 6 
pooled from two independent experiments). 
Data are shown as OD450 with the background 
of secondary antibody alone subtracted. In all 
cases, the secondary antibody alone yielded 
an OD450 value of <0.050. (C) ELISPOT detec-
tion of individual anti–-glucan IgM-produc-
ing B cells at various tissue sites in BALB/c 
mice (n = 6 per condition pooled from two 
independent experiments). (D) Anti–-glucan 
IgM-producing CD5+ and CD5 B cells sorted 
from the spleen of BALB/c mice and detected 
by ELISPOT (n = 6 per condition pooled from 
two independent experiments; *, P < 0.05 
by Mann-Whitney test). SFU, spot-forming unit. (E–G) Reactivity of tetrameric IgM homologue in catfish sera (E), human cord blood IgM (F), or rhesus 
macaque cord blood IgM (G) with -glucan and chitosan/chitin was measured by ELISA (n = 6–8 per group pooled from two independent experiments). 
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by natural IgM, we compared the ability of natural IgM   
to bind another opportunistic pulmonary fungal pathogen, 
Aspergillus fumigatus. Resting conidia, which have decreased 
quantities  of  surface  -1,3  glucan,  were  poorly  reactive 
with natural IgM, whereas conidia matured to a swollen, 
prehyphal state, leading to cell wall remodeling, and the 
display of high quantities of surface -1,3 glucan (Hohl   
et al., 2005; Steele et al., 2005) bound significant quantities 
of IgM (Fig. 2 A, IV, top). IgG present in mouse SPF serum 
was  significantly  less  reactive  with  swollen  A.  fumigatus  
conidia than IgM was (Fig. 2 A, IV, bottom) and approached 
that seen with secondary control antibody staining alone. 
These data suggest that natural IgM antibodies found in 
serum and mucosal secretions are a common opsonin for 
diverse  species  of  fungi.  Additionally,  specific  antigens   
targeted by nAbs may be more abundant or accessible dur-
ing different stages of the fungal life cycle and may be mu-
tually  recognized  by  both  membrane-bound  PRR  and 
natural IgM.
Natural IgM binds to fungal cell walls, and binding capacity 
is influenced by growth stage
We next assessed whether natural IgM antibodies are reac-
tive with the cell walls of diverse fungal species. Zymosan, 
a particulate derived from the cell wall of Saccharomyces 
cerevisiae, consisting primarily of -1,3 glucan, was incu-
bated with diluted serum from SPF mice and then assessed 
for binding of IgM by flow cytometry. We observed marked 
binding of mouse IgM from SPF serum to zymosan (Fig. 2 
A, I), and this phenotype was also present, although some-
what diminished, when assessing human cord blood IgM 
reactivity (Fig. 2 A, II). Preincubation of serum with lami-
narin partly diminished the ability of mouse SPF serum 
IgM to bind zymosan (Fig. 2 B), demonstrating specific 
binding of natural IgM to fungal cell wall -1,3 glucan. 
Additionally, a cyst-enriched preparation of P. murina dem-
onstrated high quantities of natural IgM binding when in-
cubated with mouse SPF serum (Fig. 2 A, III). To extend 
our observation that diverse fungal cell walls are recognized 
Figure 2.  Natural IgM antibodies bind 
fungal cell walls, and transfer of nAb-
containing serum from WT SPF mice enhances 
immune responses and impairs growth of 
Pneumocystis in the lungs of susceptible 
SCID mice. (A) Representative histograms of 
IgM binding. Fungal cells or fungal cell walls 
were incubated with serum diluted 1:4 in 2% 
BSA/PBS, washed, and then probed with anti-Ig 
Cy3 conjugates and studied by flow cytometry. 
Serum from BALB/c SPF mice (I) or human cord 
blood (II) was incubated with zymosan particles 
and then probed with anti–mouse IgM or anti–
human IgM conjugate antibodies, respectively 
(red line). Black line indicates primary incuba-
tion with SCID sera (I) or anti–human IgM con-
jugate antibody alone (II; the dotted line in II 
indicates unstained control). (III) Cyst-enriched 
Pneumocystis preparation incubated with BALB/c 
SPF sera followed by anti–mouse IgM conju-
gate antibody. (IV, top) A. fumigatus resting 
(solid lines) and swollen conidia (dotted lines) 
incubated with serum from SCID (black lines) or 
BALB/c SPF mice (red lines), followed by anti–
mouse IgM conjugate antibody. (bottom) Rela-
tive binding of mouse sera natural IgG (green 
line) versus natural IgM (red line) from WT SPF 
mice to A. fumigatus swollen conidia. Secondary 
antibody staining with anti–mouse IgG conju-
gate antibody was not different than when SCID 
sera control was used as primary (not depicted). 
FACS plots are representative of three indepen-
dent experiments. (B) BALB/c SPF serum diluted 1:4 in 2% BSA/PBS was preincubated with laminarin before exposure to zymosan (laminarin final concen-
tration is expressed). Particles were washed and then probed with anti–mouse IgM conjugate antibody. (C and D) Cohorts of SCID mice received a total of 
400 µl of serum (100 µl of serum i.v. and 300 µl of serum i.p.), from either SPF WT mice or SCID mice, and 1 h thereafter were challenged with Pneumo-
cystis intratracheally. Pathogen burden was determined at 5 (C) and 14 d (D) by assessing lungs for total Pneumocystis (PC) mitochondrial large subunit 
ribosomal RNA (mtLSU) subunit copy numbers by real-time PCR. Data are plotted as mean ± SEM (n = 6–8 pooled from three independent experiments;  
*, P < 0.05; **, P < 0.01). (E and F) Kinetics of IL-1 (E) and IL-6 (F) production in the lung homogenate of infected mice were determined by Luminex assay  
(n = 6 pooled from two independent experiments; *, P < 0.05). Error bars represent SEM.JEM VOL. 207, December 20, 2010 
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in the evolving host response to this infection. As host defense 
was enhanced in SCID hosts without T and B cells, nAb- 
containing serum has protective functions in the absence of 
adaptive immune mechanisms. However, despite the transfer of 
IgM-containing sera, SCID mice do not ultimately clear the 
infection (unpublished data), underscoring the requirement 
for adaptive immune responses in the clearance of infection.
To further confirm the unique functions of sIgM in host 
defense against Pneumocystis, we assessed infection in mutant 
mice unable to secrete IgM, sIgM/. C57BL/6J sIgM/ 
mice, previously reported and characterized, express B cell 
surface IgM and IgD and isotype class-switch normally to se-
crete other Ig isotypes (Boes et al., 1998a; Diamond et al., 
2003). We infected WT and sIgM/ mice and compared 
their relative ability to clear Pneumocystis infection at an 
intermediate time point in infection, 14 d after intratracheal 
challenge. sIgM/ mice had substantially impaired clearance 
of Pneumocystis relative to WT mice (Fig. 3 A), underscoring 
the unique contribution of IgM in host defense against this 
infection. Additionally, sIgM/ mice had diminished pro-
duction of IL-1 and IL-6 (Fig. 3 B) in the lungs, cytokines 
which  were  similarly  diminished  in  SCID 
mice  transferred  with  SCID  serum  lacking 
nAbs (Fig. 2). IL-1 and IL-6 are cytokines 
known to be critical for the differentiation of 
Th17 cells, a subset of T cells important in 
antifungal host resistance (Bettelli et al., 2006; 
Sutton  et  al.,  2006; Veldhoen  et  al.,  2006). 
sIgM/ mice also had enhanced production 
of IL-10 in the lungs (Fig. 3 B), a cytokine 
which  inhibits  the  kinetics  of  Pneumocystis 
Natural IgM modulates innate and adaptive immune 
responses to Pneumocystis
We assessed the relevance of the IgM isotype, the predomi-
nant isotype of nAb, in host defense against Pneumocystis in-
fection. SCID mice, which permit the growth of P . murina in 
the lungs, were transferred with complement-inactivated SPF 
serum from either WT or SCID mice. Serum was adminis-
tered in a combination of i.v. and i.p. routes, and 1 h later, 
mice were challenged intratracheally with Pneumocystis. Se-
rum containing nAbs significantly suppressed the growth of 
Pneumocystis infection in SCID mice at early and intermediate 
time points after infection (5 d and 14 d, respectively; Fig. 2, C 
and D). The transfer of serum also enhanced production of 
cytokines IL-1 and IL-6 in the lungs (Fig. 2, E and F). It has 
previously been demonstrated that signaling by the IL-1 re-
ceptor  is  required  for  host  defense  against  Pneumocystis   
pneumonia (Chen et al., 1992), and IL-6 is implicated in reg-
ulating recruitment of inflammatory cells to the lungs, dimin-
ishing numbers of neutrophils recruited into the lungs after 
Pneumocystis challenge (Chen et al., 1993). Thus, serum con-
taining nAb enhanced the production of cytokines important 
Figure 3.  Mice unable to produce sIgM have im-
paired pulmonary clearance of Pneumocystis and 
altered inflammatory responses in local DLNs and 
in lung tissue. (A and B) C57BL/6J WT and sIgM- 
deficient (KO) mice were challenged with Pneumocystis 
intratracheally, and 14 d thereafter, pulmonary Pneumo-
cystis (PC) burden (A) was assessed by real-time PCR. 
Symbols represent individual mice; horizontal lines rep-
resent the mean (n = 8–9 pooled from three indepen-
dent experiments; **, P < 0.01 by Mann-Whitney test). 
mtLSU, mitochondrial large subunit ribosomal RNA.  
(B) IL-1, IL-6, and IL-10 in lung homogenate were 
measured at 14 d (n = 6–8 pooled from two indepen-
dent experiments; *, P < 0.05 by Mann-Whitney test). 
Cytokine concentrations in uninfected lungs were all 
<10 pg/ml. Error bars represent SEM. (C) Mediastinal 
DLNs isolated from WT or sIgM KO mice 14 d after in-
tratracheal Pneumocystis challenge were gently teased 
apart, and cells from each LN were individually restimu-
lated with or without Pneumocystis antigen and  
cultured for 3 d. Supernatants were assessed for  
production of IL-5, IL-9, IL-17, and IFN- by Luminex 
assay (n = 6 mice per group pooled from two indepen-
dent experiments). Data are mean ± SEM (*, P < 0.05 by 
Mann-Whitney test). Cytokine responses without anti-
gen stimulation were <25 pg/ml in these experiments.2912 Natural IgM drives antifungal defense | Rapaka et al.
To address how antigen presentation at 
the very earliest aspects of fungal exposure in 
lung tissue is affected by nAbs, we assessed 
whether mice deficient in sIgM have im-
paired uptake or presentation of fungal cell 
wall antigen to CD11c+ APCs of the lung 
(Vermaelen  et  al.,  2001)  in  vivo. WT  or 
sIgM/  mice  were  intratracheally  chal-
lenged with FITC-zymosan and, 16 h later, 
were assessed for the frequency of CD11c+ cells that were 
FITC positive secondary to zymosan endocytosis in the lung 
parenchyma and in DLNs. In the lung tissue, we observed that 
the vast majority of CD11c+ cells were FITC positive after 
FITC-zymosan challenge, and equivalent frequencies of FITC+ 
CD11c+ cells were observed in WT and sIgM/ mice (Fig. S3), 
suggesting that sIgM is not required for CD11c+ cell recogni-
tion of zymosan in lung tissue. However, when we compared 
quantities of CD11c+ cells in the mediastinal DLNs 16 h after 
challenge, the number of recovered FITC+ CD11c+ cells was 
diminished in sIgM/ mice, suggesting that migration of 
CD11c+ APCs to the LNs is impaired in the absence of sIgM 
(Fig. 4, A and B). Thus, natural IgMs are involved in the very 
earliest aspects of fungal carbohydrate antigen recognition in 
the host, influencing trafficking of antigen-loaded CD11c+ 
cells to regional LNs.
Purified -1,3 glucan from Pneumocystis carinii is highly 
inflammatory and results in the elaboration of TNF, IL-1, 
and MIP-2 from APCs (Hoffman et al., 1993; Vassallo et al., 
2000; Carmona et al., 2006). However, purified whole intact 
clearance (Qureshi et al., 2003). Thus, IgM antibodies have   
an important role in host defense at early stages of Pneumocys-
tis infection, influencing inflammation and fungal burden in 
the lungs.
Given these alterations in inflammatory responses in the 
lung tissue, we next sought to determine whether immune re-
sponses  in  regional  LNs,  sites  of  antigen  presentation  and 
priming of adaptive immune responses, are affected by an en-
vironment deficient in sIgM. Mediastinal draining LNs (DLNs) 
were collected 14 d after Pneumocystis challenge of WT or 
sIgM/ mice, and individual DLNs were restimulated with 
Pneumocystis antigen. We observed that sIgM/ mice pro-
duced diminished quantities of the Th2 cytokines IL-5 and 
IL-9 and diminished quantities of IL-17 (Fig. 3 C). In contrast, 
we observed minimal differences in the induction of the Th1 
cytokine IFN- in sIgM/ mice. These data indicate that 
fungal antigens presented in a sIgM-sufficient environment 
produce increased Th2 and Th17 cytokines within the lungs 
and demonstrate that sIgM is critical for in vivo Th2 and Th17 
priming against Pneumocystis within pulmonary DLNs.
Figure 4.  nAbs influence the earliest aspects of 
fungal antigen presentation and infiltration of 
inflammatory cells into the lungs. (A) C57BL/6J 
WT or sIgM/ (KO) mice were intratracheally chal-
lenged with 500 µg FITC-zymosan delivered in 50 µl 
PBS. 18 h later, mediastinal DLNs were harvested and 
dissociated into single-cell suspensions. Cells were 
stained with CD11c-APC, and FITC association was 
assessed by flow cytometry. Representative WT or 
sIgM KO individual LNs are presented. (B) Recovery 
of CD11c+ FITChi cells in LNs per cohort (n = 5–9 mice 
per group pooled from two independent experi-
ments; *, P < 0.05 by Mann-Whitney test).  
(C–H) Bone marrow–derived DCs were grown in RPMI 
1640 +10% FCS + GM-CSF + IL-4. After 6 d, DCs were 
collected, washed, and cultured in serum-free RPMI 
1640. Pneumocystis cysts obtained from chronically 
infected SCID mice were unopsonized or opsonized 
with WT serum or serum from sIgM KO mice and 
added to DCs at a dose of 10 cysts per cell. Cell  
supernatants were assayed for TNF, IL-1, IL-6, or  
IL-12p40 by Luminex or IL-23 by ELISA (n = 6 mice 
per group pooled from two independent experiments;   
*, P < 0.05). In H, total RNA was extracted, and relative 
expression of Ccr7 was assayed by quantitative real-
time PCR normalized to GAPDH (n = 6 mice per 
group pooled from two independent experiments;  
*, P < 0.05). Error bars represent SEM.JEM VOL. 207, December 20, 2010 
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presentation in DLNs, we further assessed the hypothesis that 
sIgM might influence pathways of Th differentiation within 
draining lung LNs at the single-cell level.  We infected sIgM/ 
and WT mice with Pneumocystis and 14 d thereafter assessed 
frequencies of LN cells producing cytokines associated with 
Th1 (IFN-), Th2 (IL-5), or Th17 (IL-17) responses from 
mice by ELISPOT. To determine frequencies without ex-
panding the population ex vivo, LN cells were not restimu-
lated with Pneumocystis antigen. We observed that LN cells 
from sIgM/ mice challenged with Pneumocystis had signifi-
cantly lower frequencies of IL-5– and IL-17–producing cells 
relative to WT mice, whereas frequencies of IFN-–producing 
LN cells, while trending lower in sIgM/ mice, were not 
substantially different from those found in WT mice (Fig. 5 A). 
We also observed similar decreases in Th2 and Th17 responses 
but preserved Th1 responses in CD4+ T cells from DLNs in 
sIgM/ mice by intracellular staining for IL-4, IL-17, and 
IFN-,  followed  by  analysis  by  flow  cytometry  (Fig.  S4). 
These data show that sIgM is involved in the optimal pro-
duction of IL-5 and IL-17, cytokines which are associated 
with Th2 and Th17 
lineages, respectively, 
in response to fun-
gal  infection.  Our 
data  demonstrate 
organism preparations of Pneumocystis are less inflammatory, 
suggesting that glucans may not be easily accessible in intact 
organisms by macrophage PRRs such as dectin-1 (Steele et al., 
2003). To assess whether IgM opsonization affects the DC re-
sponse to this fungal pathogen, we incubated Pneumocystis 
with WT serum or sIgM/ serum before incubation with 
bone marrow–derived DCs. Incubation of DCs with unopso-
nized Pneumocystis organisms results in small increases in TNF, 
IL-1, IL-6, IL-12p40, and IL-23 (Fig. 4, C–G). However, 
opsonization with WT mouse serum resulted in significant 
increases in these cytokines. Opsonization with sIgM/ serum 
resulted in a significant attenuation of TNF, IL-1, IL-6, 
IL-12p40, and IL-23 (Fig. 4, C–G). Thus, IgM antibodies re-
active with Pneumocystis organisms enhance inflammatory re-
sponses by DCs, which may influence DC activation and Th 
priming pathways. As we had also observed a defect in DC hom-
ing in sIgM/ mice in vivo, we sought to determine whether 
opsonization of Pneumocystis affected expression of messenger 
RNA for the lymphoid homing receptor CCR7. Of note, un-
opsonized Pneumocystis induced Ccr7 expression; however, op-
sonization with WT serum, in contrast to sIgM/ serum, 
induced the highest amount of Ccr7 expression (Fig. 4 H).
As exposure to Pneumocystis in mice unable to produce 
sIgM altered production of Th2- and Th17-associated cytokines 
in mediastinal DLNs and sIgM influences fungal antigen   
Figure 5.  Mice unable to secrete IgM 
have diminished Th2 and Th17 responses 
in mediastinal LNs after Pneumocystis 
challenge and impaired Th2-type adaptive 
B cell responses. C57BL/6J WT and sIgM KO 
mice were challenged with Pneumocystis 
intratracheally. (A) 14 d after challenge, medi-
astinal LNs were harvested, and cells were 
dissociated into single-cell suspensions, enu-
merated, and assessed for production of IL-5, 
IL-17, and IFN- after 2-d culture by ELISPOT. 
In the absence of infection, spot frequencies 
are <5 spot-forming units (SFUs) per million 
cells (not depicted; n = 6 mice per group 
pooled from two independent experiments). 
(B) Before challenge, Pneumocystis inoculum 
was preopsonized with serum from either 
C57BL/6J WT or sIgM KO mice and thereafter 
administered to sIgM KO mice intratracheally. 
14 d after infection, individual LNs were col-
lected, and cells were dissociated into single-
cell suspensions, enumerated, and stimulated 
with Pneumocystis antigen in culture for 2 d. 
IL-5 and IL-17 production was measured in 
tissue culture supernatants by Luminex assay 
(n = 5–6 pooled from two independent ex-
periments). Data are mean ± SEM. (C) Serum 
was collected serially from WT and sIgM KO 
mice challenged intratracheally with Pneumo-
cystis and probed for adaptive IgG1 and IgG2c 
responses against Pneumocystis antigen.  
BALF was collected at 28 d after infection and 
probed for total IgG and IgA responses 
against Pneumocystis antigen (n = 5–6 mice/
condition/time point pooled from two inde-
pendent experiments). Error bars represent 
SEM (*, P < 0.05; **, P < 0.01 by Mann- 
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critical importance in promoting adaptive Th2 and Th17 type 
immune responses locally and systemically in response to 
Pneumocystis pulmonary infection. Routing of fungal antigen 
through  sIgM-dependent  pathways  increased  migration  of 
pulmonary APCs to DLNs and enhanced inflammatory re-
sponses in the lungs and LNs, leading to more efficient clear-
ance of pathogen in early stages of mucosal infection. Such 
alteration of antigen presentation and differential activation of 
APCs affects T cell priming and germinal center reactions, 
leading to changes in programming of B and CD4+ T cell 
type adaptive immune responses.
Almost all fungi possess a cell wall with conserved com-
position, consisting of a core of -1,3 linked glucan inter-
linked with chitin, which provides an important structural 
function for the fungal cell wall (Latgé, 2007). Although the 
manner in which these carbohydrates drive immune responses 
likely involves recognition by membrane-associated PRRs 
such as CD11b (Yan et al., 1999), dectin-1 (Brown and Gordon, 
2001), and toll-like receptors and cellular enzymes such as 
chitinases (Elias et al., 2005; Reese et al., 2007; Da Silva et al., 
2008), the role of innate antibodies in the identification of 
these structures has thus far not been evaluated. nAbs are mol-
ecules primarily of the IgM isotype, often with the capacity 
to bind more than one antigen, and are usually encoded by a 
limited set of germline genes without N-region additions 
(Baumgarth et al., 2005). Given their presence in the steady-
state, their importance in immediate immunological responses 
such as delayed-type hypersensitivity (Szczepanik et al., 2003) 
and in defense against bacterial and viral infections has been 
studied (Boes et al., 1998b; Ochsenbein et al., 1999). The rep-
ertoire, although broad, is highly restricted (Mouthon et al., 
1995), as for example, mice produce nAbs targeting the car-
bohydrate antigen Gal1-3Gal only after genetic deletion of 
an enzyme required for the production of this carbohydrate, 
and in our experiments, we note that mouse natural IgM is 
not reactive with the fungal cell wall carbohydrate mannan. 
We show that high quantities of IgM targeting -glucan and 
chitin are present in the serum of naive mice and that mice 
reared  in  germ-free  conditions  contain  these  specificities. 
Binding of serum IgM to zymosan was inhibited by lami-
narin, although only partially, demonstrating a lack of 100% 
competition by laminarin, which may be partially explained 
by residual chitin in the zymosan preparation. As the nAb 
repertoire is likely to be the first representation of B cell im-
munity in evolution, we questioned whether more primitive 
organisms produce these specificities. Catfish, among the ear-
liest species containing Igs derived from genetic recombina-
tion and containing a tetrameric homologue of IgM, possessed 
serum IgM reactivity against -glucan and chitin, suggesting 
that the capacity to make these specificities is preserved be-
tween species. Natural IgM antibodies targeting -glucan and 
chitin were also found in primate umbilical cord blood, dem-
onstrating that these specificities are conserved and develop in 
the absence of exogenous antigenic stimulation. In the mouse, 
we observed that production of these antibodies predomi-
nates in the spleen, and that CD5+ B cells purified from the 
that sIgM, which includes nAbs targeting fungal cell wall car-
bohydrate antigens, is capable of shaping Th-associated LN 
responses against fungal pathogens.
To address whether reconstitution of sIgM influences Th 
priming in LNs at the earliest time points after Pneumocystis 
exposure, Pneumocystis inoculum was preopsonized with either 
sIgM/ or WT serum and was used to intratracheally infect 
sIgM/ mice. 14 d thereafter, mediastinal LNs were collected 
and individually restimulated with Pneumocystis antigen. LNs 
from sIgM/ mice challenged with Pneumocystis preopso-
nized with WT serum produced significantly higher quanti-
ties of total IL-5 and IL-17 in culture (Fig. 5 B). There was no 
difference in IFN- production with Pneumocystis restimula-
tion with a level of 126 ± 31.6 pg/ml in WT mice and 107 ± 
25.7 pg/ml in sIgM/ mice (n = 6 each group; P > 0.05). 
This observation supports the hypothesis that opsonization of 
Pneumocystis with IgM directly promotes adaptive Th2 and 
Th17 responses in DLN inflammatory responses, at least in 
part by increasing fungal antigen trafficking to DLNs and al-
tering pathways of APC activation.
As the role of sIgM has not been assessed in the evolving 
antibody response against any fungal organism, we evaluated 
the kinetics and isotype production of antibodies formed in 
sIgM/ mice after exposure to Pneumocystis. Unexpectedly, 
we observed that the production of anti-Pneumocystis IgG1 
was significantly impaired in sIgM/ mice (Fig. 5 C). Of note, 
IgG1  is  the  predominant  anti-Pneumocystis  isotype  pro-
duced after infection in mice (Garvy et al., 1997) and is an 
antibody isotype associated with Th2 immunity. In compari-
son, serum anti-Pneumocystis IgG2c, which is an isotype asso-
ciated with Th1 immunity, was significantly increased in 
sIgM/ mice (Fig. 5 C). Both trends emerged as early as   
10 d after challenge and notably continued through 28 d after 
infection, with total quantities of IgG1 significantly lower and 
IgG2c higher in sIgM/ mice. Additionally, production of 
anti-Pneumocystis IgG and IgA at mucosal surfaces was inhib-
ited in the absence of sIgM at 28 d after infection (Fig. 5 C). 
Normal programming of B cell adaptive antibody responses 
against Pneumocystis, both systemically and at mucosal surfaces, 
requires sIgM.
DISCUSSION
We report on the significant functions of nAbs and the IgM 
isotype in host defense against the opportunistic fungal patho-
gen P . carinii. Although adaptive immune defense mechanisms 
involving CD4+ T cells are central to host defense against 
Pneumocystis  pneumonia,  we  have  identified  a  significant 
function for sIgM in host defense against fungi and demon-
strate that natural, innate antibodies and sIgM are involved in 
immunological responses at the earliest stages of fungal infec-
tion, enhance clearance of infection, and shape the evolving 
adaptive immune responses mounted by the host. Conserved 
natural IgMs target the abundant and conserved carbohydrate 
antigens present in fungal cell walls, are involved in the earli-
est stages of fungal recognition and host defense, and are of JEM VOL. 207, December 20, 2010 
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zymosan in inductive sites was impaired in the absence of 
sIgM. As DC migration is dependent on the process of cellu-
lar maturation and the expression of specific chemokine re-
ceptors mediating LN homing, which in turn is thought to 
be partly guided by the signaling pathways initiated by patho-
gen-associated molecular patterns, we believe that fungal 
cell wall carbohydrate antigens coated in IgM are processed 
through PRRs, which enhance the process of DC matura-
tion. Not understood, however, is how sIgM-coated zymosan 
specifically mediates interactions with CD11c+ cells leading 
to the promotion of migration. We demonstrate that DCs ex-
posed to Pneumocystis opsonized with serum containing IgM 
produce higher quantities of TNF, IL-1, IL-6, and IL-12p40 
than  DCs  exposed  to  Pneumocystis  opsonized  with  serum 
lacking IgM. DC chemokine responsiveness and migration to 
regional LNs have been demonstrated in models of Mycobac-
terium tuberculosis and Yersinia pestis to be dependent on   
IL-12p40 induction (Khader et al., 2006; Robinson et al., 
2008). We postulate that defective IL-12p40 induction in the 
absence of sIgM may be one mechanism by which DC mi-
gration is adversely affected in sIgM/ mice. Another area of 
future investigation is the role of complement and comple-
ment receptors as sIgM is a strong promoter of the classical 
complement pathway. sIgM may enhance complement depo-
sition on fungi, leading to recognition and DC activation 
through signaling at complement receptors. Additionally, re-
ceptors that specifically identify IgM–antigen complexes such 
as the Fc/ receptor identified in mice and humans on he-
matopoietic and other cells (Shibuya et al., 2000; Sakamoto   
et al., 2001) could be preferentially involved in the recogni-
tion of IgM-opsonized fungi by DCs, shaping the cellular 
maturation program.
Although there is evidence that a Th2-type immune re-
sponse is detrimental in host defense against various fungi, 
this has not been demonstrated to be the case in host defense 
against Pneumocystis, and notably, the Th2 response appears 
dominant in response to this infection (Garvy et al., 1997; 
Shellito et al., 2000). Additionally, the relevance of Th17 cells 
in fungal host defense is emerging. Mice treated with a neu-
tralizing antibody against IL-17 have impaired clearance of 
Pneumocystis from the lungs (Rudner et al., 2007). In systemic 
infection with Candida albicans, IL-17 receptor–deficient mice 
had  increased  tissue  fungal  burdens  and  reduced  survival, 
which appears related to neutrophil recruitment to infected 
tissues (Huang et al., 2004b). In A. fumigatus infection, it has 
been  demonstrated  that  different  isolated  fungal  cell  wall 
components, upon vaccination in mice, elicit different Th 
subsets, with glycolipids preferentially eliciting Th17 cells and 
secreted proteins preferentially eliciting Th2 cells (Bozza   
et al., 2009). Our data demonstrate that sIgM plays an impor-
tant role in the production of the Th environment after fungal 
challenge in the pulmonary DLNs, as absence of this antibody 
isotype  markedly  impaired  the  generation  of  cells  capable   
of producing IL-5 and IL-17. The numbers of specific pre-
cursor cells in the mediastinal DLNs producing IL-5, IL-9, 
and IL-17 upon restimulation with Pneumocystis were also   
spleen were the predominant subset producing these anti-
bodies. These data are consistent with findings made by other 
laboratories demonstrating that the spleen is a common site 
for nAb-secreting cells (Ochsenbein and Zinkernagel, 2000; 
Ha et al., 2006; Yang et al., 2007). Additionally, we found that 
chitin-specific IgM appears to be generated from genetic re-
combination events similar to those seen for the prototypic 
nAb for phosphatidylcholine, underscoring the limited ge-
netic repertoire seen among nAbs. We observed that serum 
IgM binds cell wall preparations such as zymosan and that 
binding is partially inhibited by laminarin, suggesting that the 
carbohydrate components of fungal cell walls are specific tar-
gets of natural IgM. Additionally, natural IgM binds Pneumo-
cystis organisms and growing A. fumigatus conidia, suggesting 
that certain antigens targeted by nAbs may be more accessible 
at certain stages of fungal cell growth. These data demonstrate 
that natural IgMs represent soluble PRRs for conserved fun-
gal cell wall carbohydrates.
Transfer of SPF WT serum into SCID mice significantly 
limited the growth of Pneumocystis in the lungs at intermedi-
ate time points after infection and enhanced production of 
IL-1 and IL-6 in the lungs, cytokines which are important 
in host defense mechanisms against this infection. The exis-
tence of protective responses mediated by nAb-containing 
serum in the absence of B and T cells underscores an intrinsic 
innate effect of nAb on host inflammatory responses and 
their ability to recognize and to enhance clearance of fungal 
organisms. The hypothesized contribution of the IgM isotype 
in these responses was confirmed our experiments in the 
sIgM/ mouse, which demonstrated impaired clearance of 
Pneumocystis at intermediate stages of infection and impaired 
production of IL-1 and IL-6 and enhanced production of 
IL-10 in the lungs. These data suggest that nAbs alter the 
routes of antigen presentation, perhaps partially inhibiting rec-
ognition of Pneumocystis directly through membrane-bound 
PRRs or through neutralizing inflammatory components such 
as shed -glucan resulting from Pneumocystis degradation. 
Of note, recent work has demonstrated that C. neoformans in-
fection in sIgM/ mice leads to increased mortality and dis-
semination of infection to the brain, underscoring the capacity 
of the IgM isotype to limit fungal infection (Subramaniam 
et al., 2010).
As the earliest aspects of Pneumocystis recognition were 
altered in the absence of nAbs, we hypothesized that the 
absence of sIgM may potentially have consequences in the 
development of adaptive immune responses. We studied the 
interaction of zymosan with pulmonary CD11c+ cells, as it is 
these cells which are hypothesized to rapidly migrate into the 
T cell zones of DLNs after instillation of antigen into the 
lungs (Vermaelen et al., 2001). By assessing how trafficking of 
the fungal cell wall carbohydrate particle zymosan occurs in 
the lungs in the absence of sIgM, we observed that pulmo-
nary CD11c+ cells were equivalently capable of internalizing 
zymosan. However, analysis of CD11c+ cells in the mediasti-
nal DLNs, DCs which have migrated secondary to activation 
and maturation, showed that the presence of DCs containing 2916 Natural IgM drives antifungal defense | Rapaka et al.
suffer from polyclonal B cell activation and polyclonal hyper-
gammaglobulinemia, with poor antibody responses to specific 
antigens (Moir and Fauci, 2008). Dysregulation of natural 
IgM could potentially play a major role in aspects of fungal 
antigen presentation, Th priming, adaptive antibody responses, 
and overall host defense influencing the phenotype of Pneu-
mocystis pneumonia susceptibility. Investigation of how HIV 
infection affects the production of nAb and particular nAb 
specificities may provide insight into host susceptibility to 
opportunistic fungi. Our experiments additionally underscore 
the concept of sIgM as a potential adjuvant in vaccine design 
against fungi such as Pneumocystis, enhancing Th2- and Th17-
type adaptive immunity.
MATERIALS AND METHODS
Mice and serum samples. 6–8-wk aged BALB/c mice and C57BL/6J 
mice  were  purchased  from  Jackson  ImmunoResearch  Laboratories  and 
BALB/c.scid mice were obtained from Taconic. Mice with a deficiency in the 
ability to secrete IgM (sIgM/), but able to express the membrane-bound 
form of IgM, on the C57BL/6J background were obtained from M.S. Diamond 
(Washington University in St. Louis, St. Louis, MO) and were previously de-
scribed (Diamond et al., 2003). The parent strain was developed by J. Chen 
(Massachusetts Institute of Technology, Cambridge, MA) and M. Carroll 
(Harvard Medical School, Boston, MA; Boes et al., 1998a). Serum samples 
from channel catfish, I. punctatus, were obtained from E. Bengtén (University 
of Mississippi, Oxford, MS). Catfish (2 kg) were obtained from the wild by 
angling (Ross Barnett Reservoir, MS) or from the United States Department 
of Agriculture–Agricultural Research Service Stoneville, MS, and maintained 
in individual tanks until bleeding by caudal venipuncture. Serum samples 
from C57BL/6 mice reared in germ-free conditions were obtained from 
S. Plevy (University of North Carolina at Chapel Hill, Chapel Hill, NC) and 
D. Peterson and J. Gordon (Washington University in St. Louis). Mice reared 
in germ-free conditions were fed standard autoclavable chow and bled at 3–4 mo 
of age. All mice were maintained in an SPF environment in microisolator 
cages within the animal care facilities of the Children’s Hospital of Pittsburgh 
under protocols reviewed and approved by the Animal Research and Care 
Committee. For longitudinal experiments, small volumes of blood were col-
lected from the periorbital sinus, and at terminal sacrifice of mice, blood was 
obtained from caudal venipuncture under anesthesia. Pooled serum for adop-
tive serum transfer experiments was obtained from SPF BALB/c or BALB/
c.scid mice aged 8 wk, via the caudal vena cava exsanguination, heated for 
1 h at 56°C to inactivate complement proteins, and stored at 80°C until use. 
Primate cord blood was obtained from the Tulane University Primate Re-
search Center. Human cord blood serum was collected from full-term new-
born patients after informed parental consent at Magee-Women’s Hospital 
(Pittsburgh, PA) according to the University of Pittsburgh Institutional Re-
view Board guidelines.
Detection of antibody responses against -glucan, chitin/chitosan, 
mannan, and Pneumocystis. Pneumocystis antigen was prepared as previ-
ously described (Zheng et al., 2001) and was dissolved in carbonate buffer, 
pH 9.5, and seeded to 96-well plates (PolySorp; Nunc) at a concentration of 
1 µg/ml. Laminarin (Sigma-Aldrich), derived from the brown algae Lami-
naria digitata and composed primarily of -1,3 linked glucan, the predomi-
nant  -glucan  linkage  found  in  fungal  cell  walls,  was  dissolved  in  PBS. 
Medium  molecular  weight  chitosan  (Sigma-Aldrich),  derived  from  crab 
shells, is a polymer of chitin that is 75–85% deacetylated. Chitosan/chitin was 
dissolved in 2% acetic acid/PBS (vol/vol) and thereafter diluted into PBS to 
a final quantity of 25 µg/ml. -1,6 linked mannan (Sigma-Aldrich) derived 
from S. cerevisiae was dissolved in PBS. Carbohydrate antigens were seeded at 
a concentration of 25 µg/ml to PolySorp 96-well plates and at 4°C. Plates 
were blocked in 10% FBS and 5% milk in PBS, and blocking buffer was used 
as a dilution buffer for serum and secondary antibodies. Sera were applied in 
diminished  in  the  absence  of  sIgM. When  sIgM/  mice 
were challenged with Pneumocystis inoculum preopsonized 
with WT serum, cells isolated from the mediastinal DLNs 
produced higher quantities of IL-17 and IL-5, suggesting that 
IgM is critically involved in generating these cytokines at sites 
of Th priming. The precise mechanism of decreased Th2 and 
Th17 priming in the absence of sIgM remains to be defined, 
although we hypothesize that the patterns of antigen presen-
tation in the sIgM-sufficient environment and differential 
activation of APCs lead to this phenotype.
We also observed that the generation of Pneumocystis-spe-
cific IgG1 antibodies was significantly diminished in the ab-
sence of sIgM, whereas IgG2c was enhanced. The dramatic 
alteration in isotype prevalence against Pneumocystis is similar 
to what is observed in IL-4/ mice challenged with Pneumo-
cystis (Garvy et al., 1997), with strong inhibition of IgG1 
production and enhanced production of IgG2a, the anti-
body isotype in BALB/c mice correlating with Th1 im-
munity.  Interestingly, our observations contrast with those 
made in the mouse influenza model, in which the kinetics 
of virus-specific IgG2a production were inhibited in sIgM/ 
mice,  but  ultimately,  quantities  of  virus-specific  IgG1  and 
IgG2a antibody produced were no different from WT mice 
(Baumgarth et al., 2000). Our data support the concept that 
IgM present at early stages of infection promotes Th2 effector 
functions while diminishing Th1 effector functions, as mani-
fested in selective Th cells promoting class-switch recombina-
tion toward IgG1. As Th17 cells produce high quantities of 
IL-21, and IL-21 is implicated in the optimal production of 
the IgG1 antibody response upon immunization (Ozaki et al., 
2002), it may be the case that higher quantities of Th17   
cells producing IL-21 are primed in an IgM-sufficient envi-
ronment. Additionally, we observed a net decrease in anti- 
Pneumocystis antibodies of the IgG and IgA isotype at the 
mucosa in the absence of sIgM. The observed decrease in 
mucosal IgA suggests that local B cell responses influencing 
the presence of antibodies at the mucosa require sIgM for 
optimal production, and this outcome may have implications 
for humoral memory responses against Pneumocystis. The re-
duced levels of anti-Pneumocystis IgA may be caused by the 
decreased frequencies of Th17 cell as these cells have been re-
cently implicated in up-regulation of the polymeric Ig recep-
tor and mucosal IgA responses (Aujla et al., 2008; Jaffar et al., 
2009). Thus, sIgM influences both specific isotype production 
as well as overall presence of antibodies against Pneumocystis in 
the mucosa, and this may be initiated by sIgM-dependent an-
tigen presentation at the very earliest stages of infection.
As individuals with X-linked hyper-IgM syndrome pos-
sess CD40L mutations, yet produce abundant IgM and are 
susceptible to Pneumocystis, it has been argued that the IgM 
antibody isotype is unimportant in host defense mechanisms 
against this infection (Mílledge et al., 2003). These studies 
demonstrate that functions of IgM are significant in host de-
fense against Pneumocystis and in the evolving adaptive re-
sponse  to  fungi. Additionally,  individuals  with  HIV-AIDS, 
who are susceptible to Pneumocystis with progressing disease, JEM VOL. 207, December 20, 2010 
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mice by a single-step method using TRIZOL reagent (Invitrogen) according 
to  the  manufacturer’s  instructions. Thereafter,  RNA  was  transcribed  to 
cDNA, and real-time PCR was performed as previously described; Pneumo-
cystis ribosomal RNA copy numbers were quantified against a standard curve 
of known Pneumocystis ribosomal RNA copy numbers as previously de-
scribed (Steele et al., 2003). Lung homogenate or tissue culture samples were 
analyzed for concentrations of 22 cytokines using a Luminex multiplex sus-
pension cytokine array (Millipore) according to the manufacturer’s instruc-
tions. Data were analyzed using Bio-Plex Manager software (Bio-Rad 
Laboratories). Fluid from the lower respiratory tract was obtained by bron-
choalveolar lavage of mice anesthetized with i.p. ketamine/xylazine as de-
scribed previously (Rapaka et al., 2007). 1 ml BALF was collected from mice 
using sterile PBS. Lavage fluids were centrifuged at 350 g, and supernatant 
was stored at 80°C until use.
Intratracheal  zymosan  challenge  and  trafficking  experiment. 
C57BL/6J WT or sIgM/ mice were intratracheally challenged with 500 µg 
zymosan covalently linked to FITC (Invitrogen), in a volume of 50 µl PBS. 
18 h after challenge, mice were sacrificed, mediastinal DLNs were collected 
and dissociated into single-cell suspensions, and RBCs were lysed. Additionally, 
lungs were digested with 25 U/ml DNase and 1 mg/ml collagenase A for 30 min 
at 37°C and then dissociated into single-cell suspensions, and RBCs were 
lysed. Cells were stained with CD11c-APC (BD) to identify APCs in the 
LNs and lungs. Cells were studied by FACSAria.
LN restimulation and IL-5, IL-17, and IFN- ELISPOT. Individual me-
diastinal DLNs were dissected from the lungs, teased apart, and placed into a 96-
well plate containing 200 µl of complete media. LN cells were restimulated with 
40,000 cysts from the Pneumocystis inoculum. 3 d after seeding, LN cells were 
pelleted, and supernatants were collected for analysis. For ELISPOT analyses, in-
dividual mediastinal DLNs were dissected, teased apart, and strained into single-
cell suspensions, depleted of RBCs, enumerated, and placed into a 96-well 
nitrocellulose membrane plate containing 100 µl of complete media for 2 d.   
IL-5 (eBioscience), IL-9, IFN- (R&D Systems), and IL-17 (R&D Systems) 
ELISPOT kits were used, and the assays were performed according to the 
manufacturers’ instruction. To assess intrinsic numbers of Pneumocystis primed 
cells secreting IL-5, IL-17, and IFN- in the DLN, without potentially ex-
panding the population, cells were not restimulated with antigen. Spot-forming 
units were quantified.
Statistical analysis. Data were analyzed using GraphPad statistical software 
(GraphPad Software, Inc.). Comparisons between groups were made with 
the Mann-Whitney U test. Significance was accepted at a value of P < 0.05.
Online supplemental material. Fig. S1 shows that the specificity of anti-
polysaccharide IgM is dependent on the variable chain. Fig. S2 shows the 
VHDJH junctions of IgH genes expressed by high and low chitosan-binding 
B cells. Fig. S3 shows lung DC uptake of FITC-zymosan. Fig. S4 shows stim-
ulated secreted IFN-, IL-4, and IL-17 in mediastinal LNs 14 d after Pneumo-
cystis  infection.  Online supplemental material  is available at http://www 
.jem.org/cgi/content/full/jem.20100034/DC1.
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